311 related articles for article (PubMed ID: 35621378)
1. Molecular docking and molecular dynamics approach to identify potential compounds in
Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK
J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378
[TBL] [Abstract][Full Text] [Related]
2. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
3.
Ayaz M; Wadood A; Sadiq A; Ullah F; Anichkina O; Ghufran M
J Biomol Struct Dyn; 2022; 40(20):10230-10238. PubMed ID: 34157942
[TBL] [Abstract][Full Text] [Related]
4. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
Ambure P; Bhat J; Puzyn T; Roy K
J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
[TBL] [Abstract][Full Text] [Related]
5. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
Khalid S; Zahid MA; Ali H; Kim YS; Khan S
BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
[TBL] [Abstract][Full Text] [Related]
6. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies.
Talia S; Benarous K; Lamrani M; Yousfi M
Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197
[TBL] [Abstract][Full Text] [Related]
7. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy.
Jabir NR; Rehman MT; Tabrez S; Alserihi RF; AlAjmi MF; Khan MS; Husain FM; Ahmed BA
Curr Pharm Des; 2021; 27(20):2425-2434. PubMed ID: 33634754
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of secondary metabolites in the bark of
Khare N; Maheshwari SK; Jha AK
J Biomol Struct Dyn; 2021 Oct; 39(16):5988-5998. PubMed ID: 32720564
[TBL] [Abstract][Full Text] [Related]
9. Multitargeted Molecular Docking and Dynamic Simulation Studies of Bioactive Compounds from
Mirza FJ; Zahid S; Amber S; Sumera ; Jabeen H; Asim N; Ali Shah SA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364071
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
11. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
[TBL] [Abstract][Full Text] [Related]
12. Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat Model.
Patel P; Faldu K; Borisa A; Bhatt H; Shah J
Curr Neurovasc Res; 2022; 19(3):344-357. PubMed ID: 36089794
[TBL] [Abstract][Full Text] [Related]
13. Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment.
Jabir NR; Rehman MT; Alsolami K; Shakil S; Zughaibi TA; Alserihi RF; Khan MS; AlAjmi MF; Tabrez S
Ann Med; 2021 Dec; 53(1):2332-2344. PubMed ID: 34889159
[TBL] [Abstract][Full Text] [Related]
14. Computational studies on the cholinesterase, beta-secretase 1 (BACE1) and monoamine oxidase (MAO) inhibitory activities of endophytes-derived compounds: towards discovery of novel neurotherapeutics.
Falade AO; Adewole KE; Ishola AA; Gyebi GA; Olajide NR
J Biomol Struct Dyn; 2023 Apr; 41(6):2540-2554. PubMed ID: 35118932
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
[TBL] [Abstract][Full Text] [Related]
16. Novel Molecular Hybrids of
Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
18. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
19. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
20. Hydroxycoumarins and some Flavonoids from
Lamrani M; Serseg T; Benarous K; Sifi I; Yousfi M
Curr Comput Aided Drug Des; 2023; 19(3):176-191. PubMed ID: 36336813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
